Smoking Cessation



Smoking Cessation

We are conducting a research study for adults who smoke cigarettes daily. This study will be evaluating the effectiveness of investigational Cytisinicline for smoking cessation.

Cytisine is a plant-based alkaloid that is believed to potentially reduce the severity of nicotine withdrawal symptoms by targeting nicotinic acetylcholine receptors (nAChRs) in the brain.  “Cytisinicline” is the generic name for cytisine.

You may be eligible if you:

  • Are 18 and older
  • Smoke an average of at least 10 cigarettes per day
  • Intend to quit smoking
  • Have tried and failed to quit smoking before

There are additional criteria to meet to qualify for this study. Volunteers who qualify for our study will receive study-related investigational medication (or placebo) and medical exams at no cost, as well as reimbursement for time and travel. No health insurance is required to participate.

For more information call
(904) 730-0166
Or sign up, our office will call you!

    This research study is enrolling at:

    Jacksonville Center for Clinical Research
    4085 University Blvd., South, Suite 1
    Jacksonville, FL 32216
    (904) 730-0166

    Learn More

    If you want us to contact you about our research studies call (904) 730-0166 or sign up below!

    Jacksonville (All Sites)
    Encore logo

    As a proven clinical research organization, we take every precaution to assure the safety of and maximize the value for our research volunteers. Qualified doctors, nurses and study coordinators on staff provide support and care throughout the research trial. Participation is always voluntary. We appreciate the time and effort that research volunteers bring to this important process.

    Copyright 2021 ENCORE Research Group